TLR7激动剂RO7020531在触发免疫激活后触发 慢性乙型肝炎患者多

StephenW

                                                                        

TLR7 agonist RO7020531 triggers immune activation after multiple doses in chronic hepatitis B patients             Reported by Jules Levin AASLD 2018 Nov 9-13 SF Edward J. Gane1, KoshAgarwal2, Rosalina Balabanska3, YonghongZhu4, Lu Gao4, Joseph F. Grippo5 , YuyanJin4, Miriam Triyatni6, Ilia Folitar7, RuchiUpmanyu8, Katerina Glavini6, EoinCoakley9, Tomas Racek6, Man-Fung Yuen10 1. Auckland Clinical Studies; 2. Institute of Liver Studies, Kings College Hospital, London; 3. AcibademCity Clinic, TokudaHospital, Sofia; 4. Roche Innovation Center Shanghai 5. Roche Innovation Center New York; 6. Roche Innovation Center Basel; 7. Roche Innovation Center Basel (former employee); 8. Roche Products Ltd;  9. Roche Innovation Center New York (former employee); 10. Queen Mary Hospital, Hong Kong

齐欢畅

关注

neilhbver

厉害，结合现有抗病毒药物，不就治愈了嘛

StephenW

回复 neilhbver 的帖子

需要谨慎,几年前，吉利德的GS9620也非常有希望.

齐欢畅